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Abstract
Background: We investigated the impact that variations in the frequency of readmissions had upon a hospital’s
standardised mortality ratio (HSMR). An adapted HSMR model was used in the study. Our calculations were based
on the admissions of 70 hospitals in the Netherlands during the years 2005 to 2009.
Methods: Through a retrospective analysis of routinely collected hospital data, we calculated standardised in-
hospital mortality ratios both by hospital and by diagnostic group (H/SMRs) using two different models. The first
was the Dutch 2010 model while the second was the same model but with an additional adjustment for the
readmission frequency. We compared H/SMR outcomes and the corresponding quality metrics in order to test
discrimination (c-statistics), calibration (Hosmer-Lemeshow) and explanatory power (pseudo-R
2 statistic) for both
models.
Results: The SMR outcomes for model 2 compared to model 1, varied between -39% and +110%. On the HSMR
level these variations ranged from -12% to +11%. There was a substantial disagreement between the models with
respect to significant death on the SMR level as well as the HSMR level (~ 20%). All quality metrics comparing both
models were in favour of model 2. The susceptibility to adjustment for readmission increased for longer review
periods.
Conclusions: The 2010 HSMR model for the Netherlands was sensitive to adjustment for the frequency of
readmissions. A model without this adjustment, as opposed to a model with the adjustment, produced
substantially different HSMR outcomes. The uncertainty introduced by these differences exceeded the uncertainty
indicated by the 95% confidence intervals. Therefore an adjustment for the frequency of readmissions should be
considered in the Netherlands, since such a model showed more favourable quality metric characteristics
compared to a model without such an adjustment. Other countries could well benefit from a similar adjustment to
their models. A review period of the data collected over the last three years, at least, is advisable.
Background
Hospital standardised mortality ratios (HSMRs) are
widely used as an indicator to assess and improve the
quality of care. HSMRs have been calculated in the UK,
USA, Canada, Australia and the Netherlands [1]. HSMR
outcomes fluctuate around 100. For example in the UK
the outcomes range from 72 to 118 and in the Nether-
lands from 62 to 142 [1,2]. The Dutch HSMR model was
developed by the Dr. Foster Intelligence Unit in London
in co-operation with Kiwa Prismant in the Netherlands.
The model adjusts for patient casemix factors including
age, sex and diagnostic group. It is based upon the
national medical registration data (LMR). In October
2010 the ‘Dutch Hospital Data’ group (DHD) distributed
the hospital specific, ‘H/SMR report 2007-2009 with
detailed information on diagnostic groups and patient
categories’, among Dutch hospitals. In this way, each hos-
pital obtained an insight into their own standardised
mortality ratios (SMRs) for 50 diagnostic groups and had
the opportunity to work on improving patient safety.
HSMRs are also made publicly available in countries, for
example in the UK’s ‘2010 Dr Foster Hospital Guide’[2].
However questions have been raised about how reliable,
valid and applicable the model really is [3-10]. It is still not
clear to what degree the current HSMR and SMR out-
comes are attributable to quality of care and can be used
to make a meaningful comparison between hospitals.
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methods have a limited impact on the hospitals position
relative to funnel plot control limits [11].
One type of potential distortion in establishing com-
parable HSMRs is caused by the failure to adjust for var-
iations in readmission frequencies. Van den Bosch, et al
[10] have demonstrated that the Dutch 2010 HSMR
model favoured hospitals with relatively many frequently
readmitted patients, regardless of disease, compared to
hospitals with many patients who are not frequently
readmitted. They were, however, not able to quantify the
effect of this upon the HSMR, because the study was
restricted to only six hospitals. In a new study more data
was made available enabling us to quantify the possible
effect in the Netherlands. We were able to compare the
HSMR outcomes of the current HSMR model to an alter-
native model with an additional adjustment for readmis-
sion frequency. In essence we asked: Does the new model
represent an improvement in the current model, based
on c-statistics, goodness of fit and explanatory power?
And if so, to what extent do HSMR and SMR outcomes
differ, comparing model 1 to model 2?
Methods
Setting
For the purpose of this model analysis the DHD group
gave its formal permission to use an anonymised LMR
dataset from 89 Dutch hospitals covering the years 2005
to 2009. Nineteen hospitals were excluded from the cal-
culation because the quality of their patient registration
data was insufficient.
This study excluded any experimental research, either
on human or animal subjects.
The HSMR model used in this study
We performed HSMR calculations using two models,
shown as model 1 and model 2.
For model 1, we used the Dr Foster model [1], applied in
the Netherlands in 2010. This Dutch model included clini-
cal admissions only, so no day cases. Furthermore only in-
hospital deaths were counted. There are differences
between the Dutch and the UK model. The Dutch model
used 50 Clinical Classifications Software (CCS) groups
based on an ICD-9 coding, whereas the UK used 56 CCS
groups based on ICD-10 coding, of which 42 groups were
the same as in the Dutch model. Furthermore, the UK
model adjusted for palliative care and for the number of
previous emergency admissions within one year. The
Dutch model did not adjust for either of these.
HSMR in brief
The HSMR (‘hospital standardised mortality ratio’) is
the ratio between the observed number of in-hospital
deaths and the predicted number of deaths, determined
by comparing the patient casemix with the national
average. The outcome is standardised around 100. A
value above 100 indicates higher mortality than average,
below 100, lower mortality. If the calculation is applied
to one of the 50 diagnostic groups, then we speak of the
SMR (‘standardised mortality ratio’).
The Dutch HSMR model of 2010 adjusts for the fol-
lowing casemix properties:y e a ro fd i s c h a r g e ,s e x ,a g e
at admission, admission type, comorbidity (charlsonin-
dex), social deprivation, month of admission, source of
referral, diagnostic group, and, in part, for the casemix
on the primary diagnostic level.
Each diagnostic group is composed of a number of
underlying diseases: ICD-9 codes (International Classifi-
cation of Diseases Ninth edition) as determined by the
Clinical Classification Software (CCS). This tool clusters
various ICD-9 diagnoses into a manageable number of
meaningful categories [12], indicated as ‘CCS diagnostic
groups’. The selected CCS diagnostic groups have a rela-
tively high mortality and together cover over 80% of the
total number of hospital deaths.
For model 2, we took model 1 and added an adjustment
for the frequency of readmission, as described by Van
den Bosch WF, et al [10]. The authors demonstrated that
frequently admitting patients was associated with lower
mortality ratios per admission, for which an additional
correction would be needed. In their publication the
patients were grouped into ‘patient view’ classes P(m).
We have also applied this to our study. Here the admis-
sion frequency m was equal to the number of times a
patient was admitted to the same hospital during the
five-year study period.
For example, a patient who was admitted ten times dur-
ing the five-year period to hospital X, to be treated for one
or more diseases, possibly with different diagnoses, was
part of the patient view class P(10) and not part of any
other patient view class. This patient contributed ten
admissions to P(10) which were all accounted for in the
regression calculation.
We were able to retrieve the number of times that a
patient was admitted through the unique patient identifi-
cation number that all of the 70 hospitals included were
using. We have grouped the patient view classes into
eight categories: m = 1, m = 2, m = 3, m = 4, m = 5-6,
m = 7-9, m = 10-20 and m > 20. This is in order to limit
the number of categories for the regression calculation
and to avoid categories becoming too small.
Agreement, or otherwise of the two models
We have calculated to what extent both models did
agree, or did not agree, as follows:
1. Relative change. To what extent did SMRmodel 1 differ
from SMRmodel 2 per CCS diagnostic group, per hospital?
Using the formula SMRdelta =( S M R model2/SMRmodel1 -1)
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Page 2 of 8*100%, we calculated the shifts for all of the 3500 SMRs
(50 diagnostic groups times, 70 hospitals), occurring when
changing from model 1 to model 2. We represented these
in a frequency distribution. In a similar way we have calcu-
lated and represented the 70 shifts that occurred for the
HSMRs of the 70 hospitals. We also compared all pairs of
death predictions of model 1 and model 2 per admission
by calculating regressions coefficients (R
2)o nt h eS M R
level and the HSMR level. These metrics were used as a
measure of statistical ‘distance’ between both models.
2. Significance scores of SMRs and HSMRs. We deter-
mined per SMR how many hospitals with a significantly
high SMR score according to model 1 turned out not to
be significantly high according to model 2. And vice
versa, in other words: how often a significantly high
SMR score in model 2 turned out not to be a signifi-
cantly high score in model 1. In a similar way we calcu-
lated these differences on the hospital level for HSMRs.
Quality metrics of the two models
We have calculated and compared the quality metrics of
the models with respect to:
1. Discrimination, expressed in ‘c-statistics’ on the
SMR level and on the HSMR level. This statistical mea-
sure indicates how well a regression model is able to
predict mortality. Each predicted outcome per admission
is compared to the observed outcome: died or survived.
A c-statistic of 0.5 has no predictive value: 50% right,
50% wrong. Values above 0.75 suggest good discrimina-
tion. A value of 1 is perfect. The overall c-statistic for
the Dutch HSMR (model 1) scored above 0.85.
2. Calibration, according to Hosmer and Lemeshow.
This represents a statistical test for goodness-of-fit that
is frequently used in risk prediction models. The test
assesses whether or not the observed event rates match
expected event rates in subgroups of the model popula-
tion. The test specifically identifies subgroups as the
deciles of fitted risk values. Models in which expected
and observed event rates in subgroups are similar, are
called well-calibrated [13].
3. Explanatory power, using the pseudo R
2 statistic
according to the ‘Nagelkerke R square’,i no r d e rt o
assess the degree to which the additional adjustment for
readmission changes the unexplained variance in the
data.
Sensitivity of the HSMR model to adjustment for
readmission
We have investigated to what extent the model was sen-
sitive to variations in the length of the period under
review. We took three scenarios: a period of review of
one year (2009), two years (2008-2009) and five years
(2005-2009). We then examined the statistical distance
between model 1 and model 2, and the three model
quality metrics on the HSMR level.
Results
We analysed the data from 89 hospitals of which 19
were excluded because they had an incomplete registra-
tion of the patient identification numbers. Therefore, we
included 70 hospitals for the regression calculation, a
total of 2494613 admissions.
Agreement between the two models
Figure 1 shows the frequency distribution of the relative
changes of the 3500 SMRs, in going from model 1 to
model 2. Similarly the changes of the 70 HSMRs of the
hospitals are shown in Figure 2. The SMR changes ran-
ged from -39% to +110% and the HSMR changes ranged
from -12% to +11%. The standard deviation of the fre-
quency distribution of the changes amounted to 12.2%
(roughly 12 SMR points) for the SMRs and to 4.1%
(roughly 4 HSMR points) of the HSMRs.
Table 1 shows the agreement that we found between
model 1 and model 2, expressed as a statistical distance
per SMR. The R
2 coefficients varied from 0.60 (COPD)
to 0.95 (intracranial injury). For the entire model the
coefficient amounted to 0.86.
Finally, we calculated per SMR for how many hospitals
a significantly high SMR score changed to not signifi-
cantly high from model 1 to model 2 and vice versa; see
Table 1. Model 1 indicated 328 SMRs in total as “higher
than expected” of which 64 were not indicated by model
2 (20%). On the other hand, model 2 indicated 313 SMRs
in total as “higher than expected” of which 49 were not
indicated by model 1 (16%). Across hospitals, model 1
indicated that 23 hospitals recorded a higher than
1
10
100
1000
10000
-
4
0
%
 
t
o
t
 
-
3
0
%
-
3
0
%
 
t
o
t
 
-
2
0
%
-
2
0
%
 
t
o
t
 
-
1
0
%
-
1
0
%
 
t
o
t
 
0
0
%
0
0
%
 
t
o
t
 
1
0
%
1
0
%
 
t
o
t
 
2
0
%
2
0
%
 
t
o
t
 
3
0
%
3
0
%
 
t
o
t
 
4
0
%
4
0
%
 
t
o
t
 
5
0
%
5
0
%
 
t
o
t
 
6
0
%
6
0
%
 
t
o
t
 
7
0
%
7
0
%
 
t
o
t
 
8
0
%
8
0
%
 
t
o
t
 
9
0
%
9
0
%
 
t
o
t
 
1
0
0
%
1
0
0
%
 
t
o
t
 
1
1
0
%
Relative shift of SMR-values
F
r
e
q
u
e
n
c
y
 
(
l
o
g
a
r
i
t
h
m
i
c
 
s
c
a
l
e
)
Figure 1 Frequency distribution of relative changes of all 3500
SMRs when changing from model 1 (Dr Foster model) to
model 2 (model with additional adjustment for readmission
frequency). * Standard deviation amounts to 12.2%.
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Page 3 of 8expected HSMR of which four were not indicated by
model 2 (17%). And, alternatively, model 2 indicated that
23 hospitals were having a higher than expected HSMR
of which four were not indicated by model 1 (17%).
H/SMR model quality metrics
For both models the ‘c-statistic’ per CCS diagnostic group
was calculated, see Table 1. Model 2 scored a higher c-sta-
tistic compared to model 1 in 47 groups out of 50. For
eighteen of these groups the scores of model 2 exceeded
the scores of model 1 by between 0.03 and 0.08. Model 1
had one diagnostic group for which the c-statistic was at
least 0.03 better compared to model 2. The c-statistic of
the HMSR across all hospitals amounted to 0.852 for
model 1 and to 0.867 for model 2 (favourable).
The results of the goodness-of-fit test are shown in
Table 2, expressed in the quality metrics of the Hosmer
and Lemeshow test. It shows that model 2 was better
calibrated compared to model 1: 7434 mismatches
(5.75% of the total deaths) for model 1 compared to
5474 (4.23%) mismatches for model 2.
Finally the overall explanatory power expressed in
pseudo R
2 statistics were calculated. These amounted to
0.259 for model 1 versus 0.282 for model 2 and so
favourable to model 2.
Sensitivity of the model to the review period of
adjustment
The overall agreement between models 1 and 2 varied,
depending on the review period, from 0.92 (one year) to
0.89 (two years) to 0.86 (five years). So a longer review
period corresponded with an increasing divergence
between the two models.
Table 3 shows how the overall model quality metrics
varied for the three review periods. A longer review
period corresponded to an increase of model quality
metric performance.
Discussion
How should we interpret the differences in model
outcomes?
In this study we have calculated and compared the H/
SMR outcomes of two models. The disagreement
between the two models was substantial, according to
the relative changes in HSMRs and SMRs.
The standard deviation of the frequency distribution
of HSMR-change amounted to 4 HSMR points, which
was substantial compared to the standard deviation of
the HSMR-frequency distribution amounting to 14
HSMR points. Moreover, these shifts introduced an
uncertainty into the HSMR outcomes that exceded the
uncertainty due to chance as indicated by the 95% confi-
dence intervals (CIs): The 95% CI of a HSMR equalled
[-2s,2 s]. On average for the 70 hospitals over five
years, the standard deviation s of the CI distribution
equalled 2.5 HSMR points.
W i t hr e s p e c tt ot h eS M R s :t h es t a t i s t i c a l‘distance’
between SMRs of model 1 and model 2 expressed in R
2
coefficients, varied from 0.60 to 0.95. Low scores indi-
cated susceptibility to adjustment for readmissions. On
average chronic diseases scored lower compared to
acute diseases as to be expected since chronic diseases
in particular often result in readmissions. There was no
particular peak among any of the main diagnostic
groups. The major diagnostic groups like cancer and
heart and lung diseases all showed substantial disagree-
ment between model 1 and model 2 due to adjustment
for readmission. The results also showed disagreement
between the models in designating hospitals as having
higher than expected H/SMRs. The percentages of dis-
agreement varied from 16% to 20%.
Bottom-line: all differences in H/SMR outcomes that
we found between the two models, cannot be attributed
to differences in the quality of care neither to ‘chance’.
They have to be attributed to the difference in the type
of model, because this is the only distinction applied in
producing the results from the same set of admissions.
T h i si m p l i e st h a tp u b l i c i s e dg o o da n db a dp r a c t i c e s ,
linked to hospital rankings based on HSMRs, can differ
substantially depending on the choice of model.
How do readmissions affect H/SMRs and how do they
occur?
We asked: how did readmissions impact the H/SMR,
how did readmissions occur and why did hospitals differ
in this respect?
For example: endlessly readmitting the same patient in
the same hospital continuously increased the denomina-
tor (predicted death) of the calculated HSMR for that
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Figure 2 Frequency distribution of relative changes of the 70
HSMRs when changing from model 1 (Dr Foster model) to
model 2 (model with additional adjustment for readmission
frequency). * Standard deviation amounts to 4.1%.
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Page 4 of 8Table 1 A comparison of SMR outcomes of model 1 and model 2
CCS
code
CCS-diagnostic group title Number of
admissions
Distance
between
model 1
and 2 (R
2)
Number of hospitals with
SMR significantly high?
c-statistic for
Model 1:
no
model 2:
yes
Model 1:
yes
model 2:
no
Model
1
Model
2
2 Septicemia (except in labour) 14647 0.83 2 1 0.760 0.783
12 Cancer of oesophagus 9703 0.74 1 3 0.730 0.763
13 Cancer of stomach 13945 0.75 0 2 0.733 0.779
14 Cancer of colon 45116 0.77 2 5 0.773 0.814
15 Cancer of rectum and anus 22246 0.72 1 3 0.771 0.817
17 Cancer of pancreas 9950 0.76 1 0 0.685 0.704
19 Cancer of bronchus, lung 76714 0.75 4 6 0.792 0.822
24 Cancer of breast 64126 0.74 2 1 0.916 0.850
29 Prostate cancer 24092 0.76 3 1 0.886 0.865
32 Cancer of bladder 44288 0.71 1 0 0.872 0.874
38 Non-Hodgkin’s lymphoma 19413 0.69 0 5 0.802 0.841
39 Leukaemias 12466 0.77 0 1 0.781 0.820
42 Secondary malignancies 69303 0.77 5 4 0.748 0.770
44 Neoplasms unspec nature or uncertain
behaviour
18982 0.63 2 1 0.805 0.840
50 Diabetes mellitus with complications 36837 0.74 1 0 0.824 0.846
55 Fluid and electrolyte disorders 29705 0.81 0 1 0.795 0.824
59 Deficiency and other anaemia 48896 0.61 0 1 0.756 0.802
85 Coma, stupor and brain damage 4286 0.92 0 0 0.801 0.815
96 Heart valve disorders 30708 0.77 1 2 0.775 0.788
100 Acute myocardial infarction 91802 0.72 1 1 0.740 0.781
101 Coronary atherosclerosis and other heart
disease
250183 0.66 1 2 0.784 0.805
103 Pulmonary heart disease 26937 0.78 0 1 0.754 0.776
106 Cardiac dysrhythmias 174923 0.72 1 2 0.828 0.860
107 Cardiac arrest and ventricular fibrillation 8118 0.89 2 2 0.739 0.764
108 Congestive heart failure, non-hypertensive 108541 0.63 4 1 0.637 0.702
109 Acute cerebrovascular disease 102295 0.86 3 0 0.744 0.761
114 Peripheral and visceral atherosclerosis 44090 0.94 1 3 0.908 0.914
115 Aortic, peripheral and visceral artery aneurysms 26538 0.93 1 1 0.871 0.887
116 Aortic & peripheral arterial embolism or
thrombosis
32881 0.75 1 1 0.882 0.892
117 Other circulatory disease 20452 0.80 0 1 0.849 0.862
122 Pneumonia 128867 0.74 2 0 0.753 0.785
127 COPD and bronchiectasis 82898 0.60 0 2 0.701 0.761
129 Aspiration pneumonitis 4485 0.79 1 1 0.644 0.688
130 Pleurisy, pneumothorax, pulmonary collapse 24798 0.78 0 0 0.812 0.827
133 Other lower respiratory disease 99460 0.77 1 0 0.854 0.866
145 Intestinal obstruction without hernia 34802 0.76 1 1 0.813 0.836
146 Diverticulosis and diverticulitis 35917 0.70 0 0 0.814 0.828
149 Biliary tract disease 135587 0.80 1 0 0.894 0.899
150 Liver disease, alcohol-related 5133 0.69 0 2 0.678 0.758
151 Other liver diseases 14584 0.80 1 0 0.771 0.807
153 Gastrointestinal haemorrhage 37229 0.71 0 1 0.738 0.764
155 Other gastrointestinal disorders 45487 0.91 0 0 0.907 0.908
157 Acute and unspecified renal failure 8804 0.73 0 0 0.723 0.760
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Page 5 of 8hospital. We have observed numerous cases where the
contribution to the denominator on behalf of a single
patient over the years aggregated to numerical values of
3 to 4. However a patient could only die once and so
any patient could maximally contribute a numerical
value of 1 to the numerator. Consequently this effect
lowered the HSMR ratio and favoured hospitals which
had many frequently readmitted patients.
There are many types of mechanisms that explain the
variation in the frequency of clinical readmission. These
could have been administrative in nature, for example
differences in administrating chemotherapy [10]. There
were also many systematic differences in treatment
practice. For example one hospital applied and recorded
a different number of clinical admissions than another
hospital did for the same combination of diagnosis and
treatment applied to the same patient. Differences also
occurred as a consequence of transferring patients back
and forth. Poor care during the initial admission may
also have triggered readmissions later. As a consequence
all these examples of increased readmissions were being
‘rewarded’ by model 1 while model 2 was correcting for
this phenomenon.
The analysis showed that the combined effect of all
these mechanisms was not restricted to some of the
diagnostic groups, but had an impact upon most of
them. Clearly the HSMR model was susceptible to an
adjustment for the frequency of readmissions in the way
we have defined it.
The analysis also showed that reducing the review per-
iod from five to two years and from two to one year,
resulted in a substantial reduction of this susceptibility.
This phenomenon may be explained as follows: It may
take several years before the readmissions of a patient con-
stitute a substantial sequence of admissions. Furthermore
a sequence might also have started long before the analysis
period started. In these cases apparently one year was not
a sufficiently long time period to capture sequences with a
substantial amount of admissions. By looking at various
years these sequences became better visible.
Choice of model: consequences for usage of H/SMR as
indicator
We considered which of the two models would be more
favourable to use and why. Since the model characteris-
tics with regard to discrimination, calibration and
Table 1 A comparison of SMR outcomes of model 1 and model 2 (Continued)
158 Chronic renal failure 14570 0.75 0 2 0.846 0.872
159 Urinary tract infections 62382 0.77 0 0 0.817 0.836
226 Fracture of neck of femur (hip) 74557 0.73 0 2 0.719 0.732
233 Intracranial injury 56535 0.95 0 1 0.939 0.941
237 Complication of device, implant or graft 76079 0.69 0 0 0.821 0.833
238 Complications surgical procedures or medical
care
67106 0.76 0 0 0.827 0.833
249 Shock 3150 0.80 1 0 0.716 0.733
Total all CCS diagnostic groups 2494613 0,86 49 64 0.852 0.867
* Per CCS diagnostic group: number of admissions; statistical distance between model 1 and model 2; number of hospitals with significance differenceso fS M R s
comparing model 1 to model 2, c-statistics for both models. The table includes results of 70 Dutch hospitals over the period 2005 - 2009
Table 2 Contingency table with Hosmer and Lemeshow
test for goodness-of-fit
Died model 1 Died model 2
Decile Observed Expected Observed Expected
1 138 268 134 231
2 498 786 469 677
3 1057 1464 997 1295
4 1888 2485 1721 2197
5 3609 4038 3002 3544
6 6181 6399 5299 5599
7 10486 10026 8999 8843
8 16797 15578 14890 14337
9 28064 26026 27112 25084
10 60625 62273 66720 67535
Percentage mismatch 5,75% 4,23%
Table 3 Comparison of HSMR model quality metrics of
model 1 to model 2 for various lengths of review period
Model 1 Model 2 Difference In favour of
Overall c-statistic
1 year period 0.857 0.866 0.009 model 2
2 year period 0.856 0.865 0.009 model 2
5 year period 0.852 0.867 0.015 model 2
% decile match hosmer
lemeshow test
1 y period 93.85% 94.13% 0.28% model 2
2 year period 93.82% 94.41% 0.59% model 2
5 year period 94.25% 95.77% 1.52% model 2
Nagelkerke R square
1 year period 0.269 0.285 0.016 model 2
2 year period 0.266 0.284 0.018 model 2
5 year period 0.259 0.282 0.023 model 2
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recommend using model 2, although this preference
does not necessarily invalidate model 1. HSMR models
in other countries may need a similar additional adjust-
ment. The impact of readmissions on the current
HSMR in the UK is not clear. The UK model adjusts for
readmissions for emergency cases. However for non-
emergency cases the model does not adjust for readmis-
sions. Moreover, admissions with different primary diag-
noses are not counted as readmissions as well.
Furthermore the UK model is restricted to a maximum
review period of one year, which is too short for the
readmission effect to become visible as demonstrated in
our study.
Am o r ef u n d a m e n t a li s s u et h a nt h ec h o i c eo fm o d e l
however, is the fact that two comparable models, such as
model 1 and model 2, may deliver such divergent out-
comes. Since there is no ‘gold standard’ one cannot state
that the one is false and the other one is true. This finding
reveals an uncertainty in HSMR outcomes that exceeds
the amount of uncertainty introduced by chance expressed
in 95% confidence intervals over the five-year period.
HSMRs and SMRs are increasingly used by physicians
to improve the quality of care in their hospitals. In par-
ticular diagnostic groups with higher than expected
mortality are the subjects of investigation. However, in a
lot of cases, the designated significance of these groups
may depend on the regression model used, not only on
the confidence intervals. The same is applicable for the
current HSMR scores in the Netherlands. Physicians
and hospital managers should be aware of this
phenomenon.
Limitations of the study
A limitation of this study was the fact that we had to
exclude 19 hospitals and so the HMSR calculation was
based on roughly 80% of the Dutch hospitals. Neverthe-
less, we think the results of our study were representa-
tive of the Netherlands and have clearly demonstrated
the impact upon the HSMR of not adjusting for fre-
quency of readmissions.
Another limitation was the fact that the Dutch HSMR
only accounts for in-hospital mortality and not for 30-
day mortality, which may favour hospitals with shorter
lengths of stay [14]. However since the effects, demon-
strated in our study, particularly concerned the phenom-
enon of the frequently returning patient, and so no 30-
days deaths, we think this potential bias does not signifi-
cantly change our conclusions.
Conclusions
The HSMR model for the Netherlands was sensitive to
adjustment for frequency of readmissions. Model 1,
without adjustment, compared to model 2, with
adjustment, produced substantially different HSMR out-
comes. The uncertainty introduced by these differences
exceeded the uncertainty indicated by the 95% confi-
dence intervals. Since model 2 turned out to be more
accurate compared to model 1 with regard to c-statis-
tics, goodness of fit and explanatory power, the authors
would prefer to apply adjustment for frequency of read-
mission. Parties, also in other countries, making use of
HSMR-calculations may decide for themselves whether
or not it is clinically relevant in their situation to
include frequent admissions in the model. In case of
adjustment, a review period of at least three years is
advisable.
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